Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)
| 12.86 Delayed Data As of Aug 09 |  -0.09 / -0.69%Today’s Change | 7.36 Today|||52-Week Range 15.25 | +9.26% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Assets | Cash | 56.1M | 45.7M | 72.0M | -- | |
| Short Term Investment Cash | 20.6M | -10.4M | 26.5M | -- | ||
| Cash & Short Term Investments | 56.1M | 45.7M | 307.3M | -- | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | -- | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | -- | -- |
| Current Assets | Other Current Assets | 259.0K | 1.4M | 6.4M | -- | |
| Current Assets | 56.3M | 47.1M | 313.8M | -- | ||
| Total Assets | Property, Plant and Equipment - Gross | 108.0K | 177.0K | 6.7M | -- | |
| Depreciation | -24.0K | -52.0K | -319.0K | -- | ||
| Other Assets | 8.0K | 25.0K | 433.0K | -- | ||
| Total Assets | 56.5M | 47.5M | 322.0M | -- | ||
| Liabilities | Accounts Payable | 212.0K | 1.2M | 10.9M | -- | |
| Accrued Expenses | 1.1M | 14.6M | 25.7M | -- | ||
| Other Current Liabilities | 1.1M | 14.6M | 26.0M | -- | ||
| Other Liabilities | 2.3M | 17.4M | 42.6M | -- | ||
| Total Liabilities | Deferred Taxes | -41.0K | -238.0K | -1.2M | -- | |
| Other Liabilities | 0.00 | 0.00 | 144.0K | -- | ||
| Total Liabilities | 2.3M | 17.4M | 42.7M | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock | 79.9M | 119.8M | 0.00 | -- | ||
| Common Equity | -25.7M | -89.7M | 279.3M | -- | ||
| Total Shareholder Equity | 54.2M | 30.1M | 279.3M | -- | ||
| Share Information | Common Shares Outstanding | 49.7M | 49.7M | 49.5M | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
